Abstract

Nearly 90% of cervical cancer cases and deaths occur in low- and middle-income countries that lack comprehensive national HPV immunization and cervical cancer screening programs. In these settings, it is difficult to implement screening programs due to a lack of infrastructure and shortage of trained personnel. Screening programs based on visual inspection with acetic acid (VIA) have been successfully implemented in some low-resource settings. However, VIA has poor specificity and up to 90% of patients receiving treatment based on a positive VIA exam are over-treated. A number of studies have suggested that high-resolution cervical imaging to visualize nuclear morphology in vivo can improve specificity by better distinguishing precancerous and benign lesions. To enable high-resolution imaging in low-resource settings, we developed a portable, low-cost, high-resolution microendoscope that uses a mobile phone to detect and display images of cervical epithelium in vivo with subcellular resolution. The device was fabricated for less than $2,000 using commercially available optical components including filters, an LED and triplet lenses assembled in a 3D-printed opto-mechanical mount. We show that the mobile high-resolution microendoscope achieves similar resolution and signal-to-background ratio as previously reported high-resolution microendoscope systems using traditional cameras and computers to detect and display images. Finally, we demonstrate the ability of the mobile high-resolution microendoscope to image normal and precancerous squamous epithelium of the cervix in vivo in a gynecological referral clinic in Barretos, Brazil.

Highlights

  • Cervical cancer remains a major global health concern with an estimated 527,600 new cases and 265,700 deaths attributed to cervical cancer in 2012

  • Screening will continue to remain important for decades for those that did not receive the vaccine prior to infection and for those infected with oncogenic human papillomavirus (HPV) types the vaccine does not protect against [7]

  • The mobile HRME (mHRME) consists of four main components: a light emitting diode (LED) to illuminate tissue, a one millimeter outer-diameter coherent fiber bundle to deliver illumination light and collect resulting fluorescence, a mobile phone to record and display the fluorescence image, and optical lenses and filters to direct light through the system

Read more

Summary

Introduction

Cervical cancer remains a major global health concern with an estimated 527,600 new cases and 265,700 deaths attributed to cervical cancer in 2012. 90% of all cervical cancer deaths occurred in developing countries [1]. In countries with the financial and human resources to support national screening [2], the incidence and mortality of cervical cancer has dropped drastically. An effective HPV vaccine has been developed[3,4,5], implementation in low resource implementation is limited largely due to the high cost of the vaccine [6]. Screening will continue to remain important for decades for those that did not receive the vaccine prior to infection and for those infected with oncogenic HPV types the vaccine does not protect against [7]. In low- to middle-income countries (LMICs) screening programs are difficult to implement due to a lack of human and financial resources and inadequate infrastructure [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call